The limitations of our study: 11 cases (15.38%) had comorbid diseases such as renal disease, cerebrovascular disease, and diabetes, and these cases had higher GDF-15 than those with COVID-19 without comorbidities which can probably indicate more severe disease but the effect of the comorbid disease on GDF-15 could not be excluded. This evidence concerns the gene GDF15 and COVID-19.